Project Grant HT94252410464
Award Date
8/15/24
Completion Date
8/14/27
Dollars Obligated
$1.5M
Federal Agency
Defense Health Agency
Awardee
Dignity Health (SKX6AXF9ZTM3)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Phoenix, AZ 85013, USA
Similar Awards
The U.S. Department of Defense's Defense Health Agency awarded a $1,119,598 Project Grant to Dignity Health, doing business as St. Joseph's Hospital and Medical Center, for the research project "AD Genetic Risk as a Prognostic Factor for Cognitive Outcomes after TBI" under the Military Medical Research and Development program (CFDA 12.420). This 4-year award, effective from September 30, 2024 to September 29, 2028, will fund innovative biomedical research focused on understanding the...
This federal Project Grant award, totaling $655,380, was provided by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant was awarded to Dignity Health's St. Joseph's Hospital and Medical Center (also known as Barrow Neurological Institute) to conduct research on maladaptive 5-HT raphe-corticolimbic plasticity underlying the development of non-motor symptoms in Parkinson's disease. The project will be performed in...
The Department of the Army Medical Command awarded a $722,545 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Dignity Health's St. Joseph's Hospital and Medical Center in San Francisco, CA. The grant will fund a 2-year research project to investigate the role of TDP-43 associated cryptic exon inclusion in C9ORF72-mediated cortical neurodegeneration. The project aims to advance understanding of the molecular mechanisms underlying neurological disorders...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,594,419.00 to The Regents of the University of California, San Francisco (UCSF) to conduct radiopathomic mapping of tumor burden for personalized management of IDH-mutant glioma. The award period runs from September 1, 2025 to August 31, 2028. As a leading academic medical center and research institution, UCSF will leverage its expertise in translational...
This Federal Project Grant award for $236,777.00 was provided by the Defense Health Agency to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). The funding supports RAPID HIGH RESOLUTION METABOLIC IMAGING FOR IMPROVED MANAGEMENT OF PATIENTS WITH GLIOMA, a research project aimed at developing advanced imaging techniques to better manage patients with glioma, a type of brain cancer. The award term runs...
The federal Project Grant award of $210,292 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research to develop "Deuterium Metabolic Imaging to Noninvasively Measure Metabolic Reprogramming in Glioblastoma", a project focused on advancing imaging techniques to better understand metabolic changes in brain cancer. The award was granted to The Washington University, a private research institution,...
The Defense Health Agency awarded a $384,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Translational Genomics Research Institute (TGen) located in Phoenix, Arizona. The grant, titled "SINGLE: SIGNATURE ENABLING GLIOMA ENROLLMENT", will support advanced biomedical research focused on transforming healthcare for military service members, veterans, and the public. Specifically, the funding will enable TGen to conduct research on genomic...
This $1,354,428 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund a family-centered e-health intervention to promote patient and caregiver well-being in adolescent and emerging adult pediatric brain tumor survivors. The grant was awarded to the Children's Hospital Medical Center in Cincinnati, Ohio, which will serve as the prime awardee. The project duration is from September 1, 2024 to August 31, 2028. The...
This federal Project Grant award for $1,399,812.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The grant is awarded to the Regents of the University of Minnesota to conduct research on outcomes and late effects in pediatric and adolescent germ cell tumor survivors. This funding will enable...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $328,000.00 in funding to The Regents of the University of California, San Francisco (UCSF) to investigate intracalvarial drug delivery strategies into skull bone marrow to create an antitumoral myeloid cell immune response to glioblastoma. The award period is from July 1, 2025 to June 30, 2027. As a leading academic medical center and research...